Lysoway Therapeutics

Lysoway Therapeutics is a biotech company in Cambridge, United States, founded in 2020. It has raised $3.4M across 1 round, most recently a $3.4M Grant in June 2026.

Lysosomal ion channel modulators for neurodegenerative diseases

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$3.4M
Last Round
$3.4M GrantJun 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Lysoway Therapeutics is a biotechnology company pioneering therapeutics targeting lysosomal ion channels for age-related neurodegenerative diseases. Based in Cambridge, Massachusetts and founded in 2020, the company develops potent small-molecule modulators of lysosomal ion channels such as TRPML1 and TMEM175, aiming to restore autophagy/lysosomal function to treat Parkinson's disease and rare diseases characterized by toxic cellular waste accumulation. Lysoway's lead program is a brain-penetrant, orally bioavailable TRPML1 agonist in preclinical/translational development, supported by grants from the Michael J. Fox Foundation.

Summary

It lists 1–10 employees. It has raised $3.4M in total across 1 round, most recently a $3.4M Grant round in Jun 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantMichael J. Fox Foundation Research GrantJun 2026
$3.4M

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lysoway Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/lysoway-therapeutics"><img src="https://indexed.vc/api/badge/company/lysoway-therapeutics" alt="Lysoway Therapeutics on Indexed.vc" width="260" height="76" /></a>